相关实验视频
Updated: Mar 14, 2026

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
10.7K
交感神经过度激活,血管功能障碍和运动不耐受症在乳腺癌的长期幸存者治疗多克索鲁比和特拉斯图祖马布基化疗
João E Izaias1,2, Artur O Sales1,2, Bruna E Ono1,2
1D'Or Institute for Research and Education (IDOR) Rio de Janeiro RJ Brazil.
Journal of the American Heart Association
|March 13, 2026
概括
长期患有乳腺癌的幸存者表现出更高的交感神经活动和血管功能受损,导致运动不耐受. 这些变化可能会增加他们治疗几年后患心血管疾病的风险.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 生理学 生理学 生理学
背景情况:
- 乳腺癌 (BC) 幸存者接受多克索鲁比和特拉斯图祖马布治疗,面临心血管疾病 (CVD) 风险升高.
- 这种心血管疾病风险增加的潜在生理机制在很大程度上是未知的.
研究的目的:
- 与对照组相比,研究长期乳腺癌幸存者的生理差异.
- 评估交感神经活动,血管功能,心脏变化,运动能力和血生物标志物.
主要方法:
- 与23名BC幸存者 (8年治疗后) 和18名对照进行了比较.
- 测量了肌肉交感神经活动,流媒体扩张,脉冲波速度,心脏功能 (心声),氧气吸收峰值和血代谢.
- 使用血治疗的人类脉内皮细胞评估内皮细胞功能.
主要成果:
- 幸存者具有较高的肌肉交感神经活动和较低的氧气吸收峰值.
- 在幸存者中,血管内皮功能受损,以减少流媒体扩张和增加内皮细胞衍生的细胞外囊泡为标志.
- 血代谢组分析显示,在各组之间有28种不同的代谢物.
结论:
- 长期患有乳腺癌的幸存者表现出同情神经系统的过度活跃和血管功能障碍.
- 这些生理变化可能会导致运动不耐受性和心血管疾病风险增加.
相关概念视频
Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Exercise and Cardiovascular Response
4.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
611
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Pathophysiology of Heart Failure
4.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.3K
Cardiomyopathy II: Dilated Cardiomyopathy
702
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
702

